This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Cano Health Temettü

Temettü kriter kontrolleri 0/6

Cano Health şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi	1.7%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Hisse başına kazanç	-US$207.63
Gelecekteki Temettü Verimi	0%

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Feb 06

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Aug 11

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

Jun 20

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Jun 09

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

May 12

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: CANO.Q şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: CANO.Q şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Cano Health Piyasaya Karşı Temettü Getirisi

CANO.Q temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (CANO.Q)	n/a
Pazarın Alt %25'i (US)	1.5%
Pazarın En İyi %25'i (US)	4.5%
Sektör Ortalaması (Healthcare)	1.7%
Analist tahmini (CANO.Q) (3 yıla kadar)	0%

Önemli Temettü: CANO.Q şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, CANO.Q şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: CANO.Q şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: CANO.Q herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

This company listing is no longer active

Cano Health Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

First Motion for Exclusivity Period Extension Approved For Cano Health, Inc.

Fourth Amended Disclosure Statement Approved for Cano Health, Inc.

Fourth Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Third Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Second Amended Reorganization Plan and Disclosure Statement Filed by Cano Health, Inc.

First Amended Joint Reorganization and Disclosure Statement Plan Filed by Cano Health, Inc.

Motion for De Minimis Asset Sale Approved for Cano Health, Inc.

Cano Health, Inc. announced delayed annual 10-K filing

Interim DIP Financing Approved for Cano Health, Inc.

Motion for Joint Administration Filed by Cano Health, Inc.

NYSE to Commence Delisting Proceedings Against Cano Health

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Cano Health, Inc. Filed for Bankruptcy

Cano Health Announces Appointment of Two New Independent Directors

Cano Health, Inc. announced delayed 10-Q filing

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings released: US$91.87 loss per share (vs US$23.34 loss in 3Q 2022)

High number of new and inexperienced directors

Cano Health Provides Nasdaq Compliance Update

Cano Health, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Cano Health, Inc. Announces the Resignation of Mark Novell as Chief Accounting Officer

Cano Health Receives NYSE Notification Letter; Plans to Regain Compliance with Listing Rules

Cano Health, Inc. Appoints Mark Kent as Chief Executive Officer

Cano Health, Inc. announced delayed 10-Q filing

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Price target decreased by 7.4% to US$2.67

Cano Health, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Cano Health, Inc. Announces Board Changes

Chief Clinical Officer recently sold US$709k worth of stock

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Issues a Response to Cano Health’s Post-Market Announcement

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

New minor risk - Insider selling

Cano Health, Inc. Announces Chief Executive Officer Changes

Chief Clinical Officer recently sold US$1.2m worth of stock

Cano Health, Inc. Announces Announces Chief Executive Officer Changes

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Posts Materials to his Website

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Cano Health, Inc. Appoints Frederick Green as Interim Chief Legal Officer

Cano Health, Inc., Annual General Meeting, Jun 15, 2023

Consensus estimates of losses per share improve by 29%

Elliot Cooperstone Sends a Letter to the Shareholders of Cano Health, Inc

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin